The Italy point-of-care glucose testing market has been witnessing significant growth during the forecast period, owing to increase in investments in healthcare infrastructure and rise in awareness for diabetes treatment. Moreover, technological advancements are driving the market growth. Furthermore, the availability of new glucose testing technologies, such as continuous glucose monitoring (CGM) and flash glucose monitoring devices, has significantly contributed to the growth of the Italy point-of-care glucose testing market. Furthermore, rise in prevalence of diabetes due to changes in lifestyle is a key factor driving the market growth. However, high cost associated with the point-of-care glucose testing devices and limited government support are the key factors restraining the growth of the Italy point-of-care glucose testing market. In addition, lack of skilled healthcare professionals, especially in rural areas is another key factor restraining the market growth. On the contrary, increase in investments in R&D initiatives is expected to bring out new and advanced glucose testing technologies in the coming years. High investments in the healthcare industry of Italy is expected to open new avenues for market players. Moreover, companies are focusing on marketing their products, highlighting their innovative features that make glucose testing easier.
The Italy point-of-care glucose testing market is segmented into product type, application, and end user. On the basis of product type, the market is classified into lancing devices & strips and blood-glucose meter. As per application, it is bifurcated into type-1 diabetes and type-2 diabetes. By end user, it is categorized into hospitals & clinics, home care settings, and others. Furthermore, the development of innovative technologies that make diabetes management easier is one of the key trends driving the market growth. Companies are launching new products that are easy to use and require small amount of samples for glucose testing. In addition, companies are concentrating on the development of digital diabetes management systems that offer automated glucose measurements and automated data analysis of glucose fluctuations.
Moreover, advancements in technology are expected to drive the growth of the Italy point-of-care glucose testing market. Furthermore, the Italy point-of-care glucose testing market has been witnessing considerable growth during the forecast period, owing to rise in prevalence of diabetes in Italy, increase in investments in the healthcare industry, and surge in geriatric population in the country. In addition, the emergence of new diabetes management technologies is expected to drive the market growth. Moreover, collaborations between hospitals, healthcare institutions, and research centers are projected to offer lucrative opportunities for the market players.
The Porter's five forces analysis assesses the competitive strength of the players in the Italy point-of-care glucose testing market. These five forces include the bargaining power of suppliers, the bargaining power of buyers, competitive rivalry, the threat of substitutes, and the threat of new entrants. The bargaining power of suppliers is low, as the suppliers have limited access to raw materials and components required for the manufacturing of point-of-care glucose testing devices. This restricts their bargaining power in the market. The bargaining power of buyers is moderate, as there are various players in the Italy point-of-Care glucose testing market, and buyers have the flexibility to switch between suppliers. The competitive rivalry in the market is high, as there are various players in the market offering similar products. The threat of substitutes is low, as there are few alternatives to glucose testing. The threat of new entrants is low, as there are many established players in the market, which makes it difficult for new entrants to compete in the Italy point-of-care glucose testing market.
Key players operating in the Italy point-of-care glucose testing market include Roche Diagnostics, Abbott Laboratories, Becton, Dickinson and Co., Bayer AG, Nova Biomedical Corporation, Beckman Coulter, Inc., EKF Diagnostics, HDI Diagnostics, Menarini Diagnostics and Arkray, Inc.
Key Benefits For Stakeholders
- Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.
- Analyze the key strategies adopted by major market players in Italy point-of-care glucose testing market.
- Assess and rank the top factors that are expected to affect the growth of Italy point-of-care glucose testing market.
- Top Player positioning provides a clear understanding of the present position of market players.
- Detailed analysis of the Italy point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.
- Identify key investment pockets for various offerings in the market.
Italy Point-of-Care Glucose Testing Market Report Highlights
| Aspects | Details |
 Forecast period | 2022 - 2032 |
 Report Pages | 79 |
 By Product Type |
|
 By Application |
|
 By End User |
|
 Key Market Players | Beckman Coulter, Inc., Arkray, Inc., Bayer AG, Menarini Diagnostics, Roche Diagnostics, EKF Diagnostics, Abbott Laboratories, Nova Biomedical Corporation, Becton, Dickinson and Co., HDI Diagnostics |
The Italy Point-of-Care Glucose Testing Market is estimated to reach $130.5 million by 2032
Roche Diagnostics, Abbott Laboratories, Becton, Dickinson and Co., Bayer AG, Nova Biomedical Corporation, Beckman Coulter, Inc., EKF Diagnostics, HDI Diagnostics, Menarini Diagnostics, Arkray, Inc. are the leading players in Italy Point-of-Care Glucose Testing Market
1. Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.
2. Analyze the key strategies adopted by major market players in italy point-of-care glucose testing market.
3. Assess and rank the top factors that are expected to affect the growth of italy point-of-care glucose testing market.
4. Top Player positioning provides a clear understanding of the present position of market players.
5. Detailed analysis of the italy point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.
6. Identify key investment pockets for various offerings in the market.
Italy Point-of-Care Glucose Testing Market is classified as by product type, by application, by end user
Loading Table Of Content...
Loading Research Methodology...
